|
|
|
| Webinar: Driving Measurable Productivity Gains in CHO Cell Culture | Developers are under increasing pressure to improve productivity and accelerate process development — all while building on established media platforms and workflows. Join Thermo Fisher Scientific experts and they explore how targeted media supplementation can enhance CHO cell culture performance, accelerate upstream process development, and drive measurable productivity gains without disrupting established workflows. Click here to learn more. |
|
|
FOCUS ON UPSTREAM MANUFACTURING |
|
|
|
In this segment from the Bioprocess Online Live event, panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss how the process-related associated with next-generation molecules like bispecifics and trispecifics complicate downstream purification efforts impurities (e.g., chain mispairings). |
|
|
|
| Cell Line Development For Bispecific Antibodies | White Paper | By Sowmya Rajendran, Indira Kottaiyl, Lynn Webster, et al., ATUM | Find out how the recently described cell line development paradigm shift, enabled by a transposon platform, can extend to the development of bispecific monoclonal antibody-producing cell substrates. |
|
|
|
| Manufacturing Of "MSC 2.0" Using Functionally Closed Systems | Application Note | By Ho Yoon Khei, Jun Yung Woo, and Khang Luu, Corning Life Sciences | Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor. |
|
|
|
| Simplified Harvest And Media Exchange In Cell Therapy | Webinar | CARR Biosystems | Scale-up often introduces shear stress and process variability. Delve into how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and performance. |
|
|
UPSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
